Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroinflammation in Parkinson’s Disease: Triggers, Mechanisms, and Immunotherapies
Tai Wang, Changhe Shi, Haiyang Luo, et al.
The Neuroscientist (2021) Vol. 28, Iss. 4, pp. 364-381
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

A New Strategy for the Regulation of Neuroinflammation: Exosomes Derived from Mesenchymal Stem Cells
Ying Ge, Jingjing Wu, Li Zhang, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 20
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 9
Is cyclooxygenase‐1 involved in neuroinflammation?
Nafiseh Ghazanfari, Aren van Waarde, Rudi Dierckx, et al.
Journal of Neuroscience Research (2021) Vol. 99, Iss. 11, pp. 2976-2998
Open Access | Times Cited: 41
The effects of bioactive components from the rhizome of gastrodia elata blume (Tianma) on the characteristics of Parkinson’s disease
Changcheng Lu, Shuhui Qu, Zhangfeng Zhong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
New insight on microglia activation in neurodegenerative diseases and therapeutics
Yucong Xu, Wei Gao, Yingnan Sun, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 16
Comprehensive Review on Potential Signaling Pathways Involving the Transfer of α-Synuclein from the Gut to the Brain That Leads to Parkinson’s Disease
Shobha Kumari, Rajeev Taliyan, Sunil Kumar Dubey
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 4, pp. 590-602
Closed Access | Times Cited: 15
Huperzine A injection ameliorates motor and cognitive abnormalities via regulating multiple pathways in a murine model of Parkinson's disease
Xinran Guo, Yuhan Wu, Qingqing Wang, et al.
European Journal of Pharmacology (2023) Vol. 956, pp. 175970-175970
Closed Access | Times Cited: 13
Varied Composition and Underlying Mechanisms of Gut Microbiome in Neuroinflammation
Rai Khalid Farooq, Widyan Alamoudi, Amani Alhibshi, et al.
Microorganisms (2022) Vol. 10, Iss. 4, pp. 705-705
Open Access | Times Cited: 18
Compound FLZ attenuates neuroinflammation through inhibiting Src/PTEN/Akt signaling pathway
Fangfang Li, Yang Zheng, Gen Li, et al.
Journal of Asian Natural Products Research (2025), pp. 1-17
Closed Access
Application of Transcranial Ultrasound in the Diagnosis and Treatment of Parkinson’s Disease
沅蔚 李
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 1256-1263
Closed Access
Research progress in the early diagnosis of Parkinson’s disease
LinLin Xie, LuDong Hu
Neurological Sciences (2022) Vol. 43, Iss. 11, pp. 6225-6231
Closed Access | Times Cited: 16
Parkinson’s Disease Dementia Patients: Expression of Glia Maturation Factor in the Brain
Ramasamy Thangavel, Harleen Kaur, Iuliia Dubova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1182-1182
Open Access | Times Cited: 3
The Neuroprotective Effects of Agmatine on Parkinson’s Disease: Focus on Oxidative Stress, Inflammation and Molecular Mechanisms
Mohammad Yasin Zamanian, Mozhgan Nazifi, Lusine Khachatryan, et al.
Inflammation (2024)
Closed Access | Times Cited: 3
Correlations of gray matter volume with peripheral cytokines in Parkinson's disease
BaoLing Chen, Hang Zhou, XinZi Liu, et al.
Neurobiology of Disease (2024) Vol. 201, pp. 106693-106693
Open Access | Times Cited: 3
Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease
Neha Kanojia, Komal Thapa, Gagandeep Kaur, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 79, pp. 104074-104074
Closed Access | Times Cited: 12
Pharmacological interventions targeting α-synuclein aggregation triggered REM sleep behavior disorder and early development of Parkinson's disease
Lida Du, Xiaoli He, Xiaonuo Fan, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108498-108498
Closed Access | Times Cited: 7
Myeloid-specific blockade of notch signaling alleviates dopaminergic neurodegeneration in Parkinson’s disease by dominantly regulating resident microglia activation through NF-κB signaling
Shi-Qian Liang, Penghui Li, Yiyang Hu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Research progress of cell treatment strategy in Parkinson's disease
Yinglong Peng, Jinwei Chen, Hengxiao Hu, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104061-104061
Open Access | Times Cited: 2
Neutrophils in the Focus: Impact on Neuroimmune Dynamics and the Gut–Brain Axis
Antea Kršek, Lara Batičić
Gastrointestinal Disorders (2024) Vol. 6, Iss. 3, pp. 557-606
Open Access | Times Cited: 2
Total Glucosides of White Paeony Capsule ameliorates Parkinson's disease-like behavior in MPTP-induced mice model by regulating LRRK2/alpha-synuclein signaling
Hongyan Li, Deshui Liu, Libo Li, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117319-117319
Closed Access | Times Cited: 6
Baseline cerebral structural morphology predict freezing of gait in early drug-naïve Parkinson’s disease
Yuting Li, Xiaofei Huang, Xiuhang Ruan, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Exploring the Therapeutic Effects of Multifunctional N-Salicylic Acid Tryptamine Derivative against Parkinson’s Disease
Xuelin Li, Shuzhi Wang, Shan Duan, et al.
ACS Omega (2023) Vol. 8, Iss. 31, pp. 28910-28923
Open Access | Times Cited: 4
Implications of COVID-19 in Parkinson’s disease: the purinergic system in a therapeutic-target perspective to diminish neurodegeneration
Júlia Leão Batista Simões, Geórgia de Carvalho Braga, Samantha Webler Eichler, et al.
Purinergic Signalling (2024) Vol. 20, Iss. 5, pp. 487-507
Closed Access | Times Cited: 1
Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease
Yongyan Fan, Jianjun Ma, Dawei Yang, et al.
European Journal of Neuroscience (2024) Vol. 59, Iss. 10, pp. 2702-2714
Open Access | Times Cited: 1
Sjögren’s syndrome and Parkinson’s Disease: A bidirectional two-sample Mendelian randomization study
Xin Cai, Zexu Jin, Shaoqin Zhang, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0298778-e0298778
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top